QuickSee found convenient, accurate in pediatric refraction
Handheld, open-view design enables effective outreach A new study published in PLoS ONE, “Assessment of the QuickSee wavefront autorefractor for characterizing refractive errors in school-age children,” finds QuickSee ideally suited to refracting children in school screenings and public health outreach. The study, conducted at the Ophthalmology Department of Fundación Jiménez Díaz Hospital included 123 children […]
PlenOptika Director of Engineering named 2020 IAPB Eye Health Hero
Carlos Hernández recognized as an innovator in the global effort to improve vision Boston, MA—PlenOptika, a biomedical technology company bringing cutting-edge vision technology to front-line vision care professionals worldwide, announced today that Carlos Santiago Hernández, Director of Engineering, was named an Eye Health Hero in the Innovators category for 2020 by The International Agency for the […]
QuickSee nominated for 2020 Silmo d’Or awards
We’re pleased to announce that QuickSee by PlenOptika was nominated for SILMO d’Or in the Material / Equipment category by SILMO Paris, one of Europe’s largest annual gatherings for the optical and eyewear industry. (Due to the international COVID-19 crisis, the annual gathering was cancelled and SILMO announced online continuation of professional exchanges, including the […]
QuickSee found most accurate portable autorefractor in independent review
A new independent literature review published in the Journal of Telemedicine and Telecare, “Better one or two? A systematic review of portable automated refractors,” finds QuickSee the most accurate portable autorefractor for vision care providers considering practice adaptations to overcome the COVID-19 pandemic. Research on QuickSee and other portable autorefractors was analyzed on a range of criteria including […]
IAPB Standard List adds QuickSee handheld autorefractor
This month the International Agency for the Prevention of Blindness (IAPB) added QuickSee to its esteemed Standard List. “We are thrilled to be included in the Standard List,” said Shivang Dave, PlenOptika CEO and one of QuickSee’s inventors. “As a leading organization in the fight to prevent blindness and improve eye health, IAPB’s evaluation of […]
QuickSee featured in ASME Foundation video
ASME Foundation Read more at ASME Foundation Recent news
PlenOptika recognized in Essilor See Change 2019 Report
In its 2019 report, Eliminating Poor Vision in a Generation, Essilor See Change identified PlenOptika as a leading technology developer helping to meet the global challenge of poor vision. Among many other details of the challenge, the report cited the relative inaccessibility of tools to diagnose refractive errors for billions of people. “Autorefractors are costly and […]
Up to 2.5 Billion People Need Glasses: Can This Hardware Innovation Deliver?
by Paul ScottNext Billion This time last year, Shivang Dave and his colleague Aaron Chang were sitting at a table in the District Architecture Center in downtown Washington, D.C., patiently taking questions as they watched a rotating group of engineers, industrial designers, manufacturing and supply chain experts, and journalists tinker with the oversized pair of […]
PlenOptika CEO Dr Shivang Dave keynotes New England College of Optometry 2018 Visionaries Event
Second year students at the New England College of Optometry were invited to attend a keynote lecture by Dr. Shivang R. Dave, PhD, Co-founder and CEO of PlenOptika. Dr. Dave is a passionate speaker about global health and entrepreneurship. He has over a decade of entrepreneurial experience working to innovate, translate, and commercialize three separate […]
PlenOptika to Release QuickSee Wavefront Refractor
Vision Monday Product: QuickSee Wavefront Refractor Top Line: PlenOptika, a biomedical technology company based in Allston, Mass., has completion the production process for the QuickSee Wavefront Refractor and plans to release the device in February. Upon final FDA registration and availability, PlenOptika’s QuickSee will be supplied to U.S. optometrists and other vision care professionals directly […]